Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan.
暂无分享,去创建一个
K. Tanabe | Takeshi Kimura | K. Kozuma | J. Yamaguchi | M. Awata | J. Aoki | H. Nie | M. Nanasato | Hajime Kusano | N. Shiode